Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1978 1
1979 1
1983 1
1989 1
1991 1
1994 1
1997 1
1998 1
2002 1
2003 2
2005 2
2006 1
2007 1
2009 4
2010 4
2011 4
2012 1
2013 15
2014 16
2015 8
2016 5
2017 3
2018 3
2019 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators. Fervenza FC, et al. N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427. N Engl J Med. 2019. PMID: 31269364 Clinical Trial.
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
Barbour SJ, Fervenza FC, Induruwage D, Brenchley PE, Rovin B, Hladunewich MA, Reich HN, Lafayette R, Aslam N, Appel GB, Zand L, Kiryluk K, Liu L, Cattran DC; MENTOR Trial Investigators. Barbour SJ, et al. Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1283-1293. doi: 10.2215/CJN.0000000000000237. Epub 2023 Jul 20. Clin J Am Soc Nephrol. 2023. PMID: 37471101 Free PMC article.
Dengue-associated kidney disease.
Lizarraga KJ, Nayer A. Lizarraga KJ, et al. Among authors: nayer a. J Nephropathol. 2014;3(2):57-62. doi: 10.12860/jnp.2014.13. Epub 2013 Dec 28. J Nephropathol. 2014. PMID: 24772398 Free PMC article. Review.
Pre-uremic calciphylaxis.
Nayer A, Virmani S, Gonzalez-Suarez M, Goez-Gutierrez E, Rosenberg AE, Salman LH, Asif A. Nayer A, et al. Iran J Kidney Dis. 2014 May;8(3):252-6. Iran J Kidney Dis. 2014. PMID: 24878953
Calciphylaxis.
Neild GH, Nayer A, Salman L, Asif A. Neild GH, et al. Among authors: nayer a. Clin Kidney J. 2013 Dec;6(6):653-4. doi: 10.1093/ckj/sft110. Epub 2013 Sep 20. Clin Kidney J. 2013. PMID: 26120460 Free PMC article. No abstract available.
Amyloid A amyloidosis with subcutaneous drug abuse.
Mendoza JM, Peev V, Ponce MA, Thomas DB, Nayer A. Mendoza JM, et al. Among authors: nayer a. J Renal Inj Prev. 2013 Nov 2;3(1):11-6. doi: 10.12861/jrip.2014.06. eCollection 2014. J Renal Inj Prev. 2013. PMID: 25340157 Free PMC article.
70 results